Marked decrease in Loa loa microfilaraemia six and twelve months after a single dose of ivermectin

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 5, 1997, Pages 593-594

  Gardon, J ^a   Kamgno, J ^a   Folefack, G ^b   Gardon Wendel, N ^a   Bouchite B ^a   Boussinesq, M ^a,c  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b Mbandjock Hospital   (Cameroon)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Cameroon; Chemotherapy; Ivermectin; Loa loa; Loiasis

Indexed keywords

ANTHELMINTIC AGENT; IVERMECTIN;

ARTICLE; BLOOD SMEAR; BRAIN DISEASE; CAMEROON; DISEASE SEVERITY; DRUG EFFICACY; FILARIASIS; GIEMSA STAIN; HUMAN; LOA LOA; MAJOR CLINICAL STUDY; ONCHOCERCIASIS;

LOA LOA;

EID: 0030726158     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90041-9     Document Type: Article

References (2)

1. Boussinesq, M., Gardon, J., Gardon-Wendel, N., Kamgno, J., Ngoumou, P. & Chippaux, J. P. (in press). Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. American Journal of Tropical Medicine and Hygiene.
2. Chippaux, J. P., Boussinesq, M., Gardon, J., Gardon-Wendel, N. & Ernould, J. C. (1996). Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitology Today, 12, 448-450.